EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cancer risks associated with BRCA1 and BRCA2 : Overview and management

Kelsey E Breen iD, Shagun Vashisth, Ying L Liu iD

Cancer · 2026

DOI: 10.1002/cncr.70635 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, 2026. Verfasst von Kelsey E Breen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: BRCA2 Protein, BRCA1 Protein, Neoplasms. Die Arbeit nennt 92 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The BRCA1 and BRCA2 tumor suppressor genes are integral to the repair of DNA double‐strand breaks. Therefore, germline pathogenic variants (PVs) in either of these genes are associated with an increased risk of developing hereditary cancers. For over 30 years, studies have demonstrated a well established and markedly increased lifetime risk of female breast cancer and ovarian cancer for individuals with a PV in BRCA1 or BRCA2 . Additional canonical cancers include prostate cancer, pancreatic cancer for males and females, and male breast cancer. Several noncanonical cancers have also been reported in association with BRCA1 or BRCA2 , including stomach cancer and endometrial cancer. This review summarizes the established and evolving cancer risks associated with germline PVs in BRCA1 or BRCA2 as well as current clinical management recommendations. With increased uptake and diversified utility of germline genetic testing, this summary provides a current overview for clinical management of both male and female individuals with a PV in BRCA1 or BRCA2 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinBRCA1 ProteinNeoplasmsHumansFemaleGerm-Line MutationGenetic Predisposition to DiseaseMaleGenetic TestingOvarian NeoplasmsGenes, BRCA2

Stichwörter der Autor:innen

BRCA1BRCA2cancer riskclinical managementhereditary cancer

Substanzen

BRCA2 protein, humanBRCA2 ProteinBRCA1 ProteinBRCA1 protein, human

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Kelsey E Breen, Ying L Liu

Zitieren

APA

Breen, K. E., Vashisth, S., & Liu, Y. L. (2026). Cancer risks associated with BRCA1 and BRCA2 : Overview and management. Cancer. https://doi.org/10.1002/cncr.70635

Vancouver

Breen KE, Vashisth S, Liu YL. Cancer risks associated with BRCA1 and BRCA2 : Overview and management. Cancer. 2026. doi:10.1002/cncr.70635

BibTeX
@article{Breen2026,
  author = {Breen, Kelsey E and Vashisth, Shagun and Liu, Ying L},
  title = {Cancer risks associated with BRCA1 and BRCA2 : Overview and management},
  journal = {Cancer},
  year = {2026},
  doi = {10.1002/cncr.70635}
}
Kostenlos starten →